Pediatric Hearing Loss

FDA approves 1st gene therapy for genetic hearing loss

FDA approves first gene therapy for genetic hearing loss

The Food and Drug Administration on Thursday approved Regeneron’s Otarmeni, the first gene therapy for genetic hearing loss

· 16h

New Gene Therapy Enables Children With a Rare Form of Deafness to Hear

· 15h · on MSN

FDA approves first gene therapy for inherited deafness, shown to restore hearing for children with rare condition

· 39m

Regeneron FDA approval: gene therapy for inherited deafness free

The FDA approved Regeneron's Otarmeni on April 23, making it the first gene therapy for inherited hearing loss — and Regeneron said it will make the treatment available at no cost to eligible patients...

STAT · 1d

Gene therapy trial for deafness adds evidence to drug’s efficacy

Becker's Hospital Review · 22h

Gene therapy restores hearing to 90% of patients in deafness study

KPLC

Health Headlines: Hearing loss in children

BOSTON, Mass. (Ivanhoe Newswire) - Can you hear me now? Well, 26 million men and women have trouble hearing. The impact of hearing loss can be profound. It can lead to the loss of communication, social isolation, and even increase the risk of dementia.

Gene therapy for a rare type of deafness shows lasting results

Researchers say a gene therapy allowed deaf children and adults as old as 32 to hear for the first time. The benefits have persisted for more than two years for some patients.